Anggot, Euhanna .
HRN: 23-05-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/08/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
12/08/2022
12/15/2022
IV
18mg
Q24hrs
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes